PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Lonza Launches the PyroCell Monocyte Activation Test System for Reliable and Sustainable in vitro Pyrogen Testing

Lonza expands upon their QC testing portfolio with the launch of the PyroCell™ MAT System, a highly sensitive and sustainable Monocyte Activation Test (MAT) suitable...
Continue Reading →
News

Cobra Biologics selected to manufacture plasmids for Phase I clinical trial of Scancell’s COVID-19 vaccine in 2021

Oxford and Keele, UK, 2 October 2020. Cobra Biologics (Cobra), part of the Cognate BioServices family, an international CDMO manufacturer of biological mat...
Continue Reading →
News

MACKWELL SOLUTIONS SIGNS PARTNERSHIP DEAL WITH MEDI-IMMUNE

Mackwell Solutions has entered into a deal with Medi-Immune to design, develop and manufacture a range of products based on their innovative disinfection technology,...
Continue Reading →
News

Inceptua receives approval of marketing authorization transfer of Jetrea® (ocriplasmin) for the treatment of symptomatic vitreomacular adhesion

Life Science Newswire – Inceptua Group – pharmaceutical company and service partner announces that the European Commission (EC) has approved the transfer o...
Continue Reading →
News

Aptar Pharma to Unveil its State-of-the-Art Virtual Booth at CPhI Festival of Pharma; Platinum Sponsor and Finalist for Four CPhI Pharma Awards

Aptar Pharma, a global leader in drug delivery systems, services and active packaging solutions, is pleased to announce its Platinum Sponsorship of the CPhI Festi...
Continue Reading →
News

Vertex, CRISPR Therapeutics’ sickle cell gene therapy wins PRIME designation

Vertex Pharmaceuticals and CRISPR Therapeutics have been awarded a Priority Medicines (PRIME) designation from the European Medicines Agency for their CRISPR/Cas9 ge...
Continue Reading →
News

Owlstone Medical’s breath biopsy test improves detection of liver disease

Cambridge-based Owlstone Medical has announced new results from a study of its breath-based diagnostic test for liver disease, including Nonalcoholic Fatty Liver Dis...
Continue Reading →
News

Digital tech has health benefits for dementia patients, project finds

A project under the NHS’s Widening Digital Participation Programme has found that digital technology such as iPads and Alexa devices can have benefits to the health ...
Continue Reading →
News

FDA and EMA accept regulatory submissions for UCB’s bimekizumab

The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have both accepted marketing application submissions for UCB’s psoriasis treatment ...
Continue Reading →
News

Verona Pharma launches late-stage COPD trial programme

Verona Pharma has initiated phase III trials to evaluate the safety and efficacy of nebulised ensifentrine in patients with moderate-to-severe chronic obstructive pu...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026